Generics
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
650
NCT06282692
INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old
Phase: Phase 3
Role: Collaborator
Start: Jun 19, 2023
Completion: Jul 19, 2024
NCT06272253
UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects
Phase: Early Phase 1
Start: Sep 19, 2023
Loading map...